Top Story

Myocardial Infarction
COPD
Beta blockers show no additional risk after myocardial infarction in COPD patients
Research finds that beta-blocker use after a first-time MI was associated with a lower mortality in patients with COPD with no increased risk.
Featured
Light Physical Activity
COPD
Light physical activity can help patients with COPD live longer
Getty Images 2199475157
Pulmonary
RNA-based testing can improve diagnostic accuracy, treatment selection in NSCLC patients
Latest News
Pulmonary drug market forecast
Sponsored
Pulmonary drug market forecast
July 21, 2026
Getty Images 939771318
How lung cancer can hijack the nervous system
July 24, 2026
Getty Images 2231226744
Novel peptide could eliminate harmful inflammation at its source
July 23, 2026
Gang Liu, PhD
Vitronectin opens door to novel PF therapies
July 23, 2026
Getty Images 2231226744
Asthma
Novel peptide could eliminate harmful inflammation at its source
Asthma
Kinaset Therapeutics announces first patient dosing in phase 2b of severe asthma trial
Asthma
Overlooked hidden airways disease
Asthma
Why air pollution exacerbates asthma in some but not all
Myocardial Infarction
COPD
Beta blockers show no additional risk after myocardial infarction in COPD patients
COPD
Light physical activity can help patients with COPD live longer
COPD
Usage of COPD treatment options lower among Black population
COPD
Virtual reality could help ease anxiety and depression in COPD patients
Getty Images 2199475157
Pulmonary
RNA-based testing can improve diagnostic accuracy, treatment selection in NSCLC patients
Pulmonary
TLR5 deficiency linked to IPF risk
Pulmonary
How lung cancer can hijack the nervous system
Pulmonary
Vitronectin opens door to novel PF therapies
Spotlight
Notable stories and studies
CDC vaccine schedules
Presented by Ascend Media
CDC vaccine schedules
Pulmonary drug market forecast
Presented by Ascend Media
Pulmonary drug market forecast
Advocate for better air
Presented by Ascend Media
Advocate for better air
More from Pulmonary
Kinaset Therapeutics announces first patient dosing in phase 2b of severe asthma trial
Study evaluates frevecitinib (KN-002), an inhaled pan-JAK inhibitor, in patients receiving medium-to-high dose ICS/LABA therapy.
July 23, 2026
Getty Images 1445996148
Usage of COPD treatment options lower among Black population
Research highlights inequities in COPD care among minority groups.
July 21, 2026
Copd Black Population
Virtual reality could help ease anxiety and depression in COPD patients
In-depth analysis suggests the technology may serve as a valuable addition to pulmonary rehabilitation.
July 21, 2026
Vr Anxiety
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
Advocate for better air
Silicosis breakthrough: Epithelial cells are key activators
Scientists disprove previous assumptions that the incurable lung disease is initiated by immune cells.
July 16, 2026
Michelle Tate, PhD, and Maggie Lam, PhD
Rare lung disease linked to TMEM63B gene mutation
Breakthrough research shows the severe childhood lung disease is caused by biallelic loss-of-function TMEM63B variant.
July 15, 2026
Getty Images 166021086
Trial to examine treatment for COPD-related muscle loss
The novel, first-in-class therapy targets an area where no approved pharmacological treatments currently exist.
July 15, 2026
Sarcopenia2
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
Cognitive, physical limitations shown to impact COPD inhaler use
Researchers associate mental impairment and nonfunctional manual dexterity to inhaler misuse and recommend comprehensive education.
July 15, 2026
Inhaleruse
Overlooked hidden airways disease
Oscillometry offers a more sensitive diagnostic alternative to normal lung function tests.
July 14, 2026
Getty Images 1420685169
Why air pollution exacerbates asthma in some but not all
Investigators identify how genetic factors influence individual reaction to harmful fine particulate matter.
July 14, 2026
Getty Images 94146417
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
Genetic testing alters pulmonary care
Assessing telomere length in patients with pulmonary fibrosis could improve diagnosis and condition management.
July 9, 2026
Getty Images 1415206606
Public dataset aids tumor diagnosis, decision-making
The openly accessible research can help clinicians differentiate benign and malignant pulmonary lesions.
July 9, 2026
Getty Images 1574418756
Mobile app could help monitor flare-ups in COPD, asthma
Voice changes can signal when an exacerbation is imminent and alert the user.
July 8, 2026
Voice Smartphone
Most Popular
Mobile app could help monitor flare-ups in COPD, asthma
Silicosis breakthrough: Epithelial cells are key activators
Genetic testing alters pulmonary care
Public dataset aids tumor diagnosis, decision-making
Kinaset Therapeutics announces first patient dosing in phase 2b of severe asthma trial
Cognitive, physical limitations shown to impact COPD inhaler use